Neuropathological hallmarks in autopsied cases with mitochondrial diseases caused by the mitochondrial 3243A>G mutation.
MELAS
choroidal epithelial cell swelling
mitochondrial 3243A>G mutation
mitochondrial vasculopathy
mtDNA heteroplasmy
stroke-like episodes
Journal
Brain pathology (Zurich, Switzerland)
ISSN: 1750-3639
Titre abrégé: Brain Pathol
Pays: Switzerland
ID NLM: 9216781
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
received:
26
03
2023
accepted:
07
07
2023
medline:
23
10
2023
pubmed:
3
8
2023
entrez:
3
8
2023
Statut:
ppublish
Résumé
The mitochondrial (m.) 3243A>G mutation is known to be associated with various mitochondrial diseases including mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Their clinical symptoms have been estimated to occur with an increased mitochondrial DNA (mtDNA) heteroplasmy and reduced activity of oxidative phosphorylation (OXPHOS) complexes, but their trends in the central nervous system remain unknown. Six autopsied mutant cases and three disease control cases without the mutation were enrolled in this study. The mutant cases had a disease duration of 1-27 years. Five of six mutant cases were compatible with MELAS. In the mutant cases, cortical lesions including a laminar necrosis were frequently observed in the parietal, lateral temporal, and occipital lobes; less frequently in the frontal lobe including precentral gyrus; and not at all in the medial temporal lobe. The mtDNA heteroplasmy in brain tissue samples of the mutant cases was strikingly high, ranging from 53.8% to 85.2%. The medial temporal lobe was preserved despite an inhospitable environment having high levels of mtDNA heteroplasmy and lactic acid. OXPHOS complex I was widely decreased in the mutant cases. The swelling of smooth muscle cells in the vessels on the leptomeninges, with immunoreactivity (IR) against mitochondria antibody, and a decreased nuclear/cytoplasmic ratio of choroidal epithelial cells were observed in all mutant cases but in none without the mutation. Common neuropathological findings such as cortical laminar necrosis and basal ganglia calcification were not always observed in the mutant cases. A high level of mtDNA heteroplasmy was observed throughout the brain in spite of heterogeneous cortical lesions. A lack of medial temporal lesion, mitochondrial vasculopathy in vessels on the leptomeninges, and an increased cytoplasmic size of epithelial cells in the choroid plexus could be neuropathological hallmarks helpful in the diagnosis of mitochondrial diseases.
Identifiants
pubmed: 37534760
doi: 10.1111/bpa.13199
pmc: PMC10580013
doi:
Substances chimiques
DNA, Mitochondrial
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13199Informations de copyright
© 2023 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology.
Références
Am J Physiol Endocrinol Metab. 2017 Sep 1;313(3):E292-E302
pubmed: 28559437
Can J Biochem Physiol. 1959 Aug;37(8):911-7
pubmed: 13671378
Sci Rep. 2018 Aug 8;8(1):11887
pubmed: 30089816
Diabetes Res Clin Pract. 2001 Dec;54 Suppl 2:S45-56
pubmed: 11733109
PLoS One. 2016 Feb 11;11(2):e0148709
pubmed: 26867126
Acta Neuropathol. 1987;74(3):226-33
pubmed: 3673514
Neurology. 2005 Dec 27;65(12):1863-72
pubmed: 16237129
Nutrients. 2021 Aug 29;13(9):
pubmed: 34578904
Mol Genet Metab. 2022 Jan;135(1):63-71
pubmed: 34991945
Rinsho Shinkeigaku. 2008 Nov;48(11):1010-2
pubmed: 19198147
Biochim Biophys Acta Mol Basis Dis. 2020 Aug 1;1866(8):165798
pubmed: 32304740
Nature. 1990 Dec 13;348(6302):651-3
pubmed: 2102678
Brain. 1995 Jun;118 ( Pt 3):721-34
pubmed: 7600089
Curr Opin Clin Nutr Metab Care. 2011 Jul;14(4):354-9
pubmed: 21505329
Am J Med Genet. 1996 Apr 24;62(4):404-9
pubmed: 8723072
Pediatr Pulmonol. 2023 Jan;58(1):271-278
pubmed: 36205439
Am J Neurodegener Dis. 2014 Mar 28;3(1):19-32
pubmed: 24754000
Ageing Res Rev. 2022 Mar;75:101569
pubmed: 35051643
Crit Care. 2013 May 24;17(3):R92
pubmed: 23706007
Mitochondrion. 2009 Apr;9(2):144-8
pubmed: 19460295
Front Cell Dev Biol. 2021 Mar 16;9:611922
pubmed: 33816463
Helicobacter. 2020 Oct;25(5):e12732
pubmed: 32713122
Endocr Res. 2011;36(4):142-8
pubmed: 21973233
Biosci Biotechnol Biochem. 2018 Dec;82(12):2168-2175
pubmed: 30240332
Oncotarget. 2017 Mar 7;8(10):17115-17126
pubmed: 28179577
Ann N Y Acad Sci. 2010 Jul;1201:104-10
pubmed: 20649546
Curr Neurovasc Res. 2005 Jan;2(1):29-45
pubmed: 16181098
J Neuropathol Exp Neurol. 2004 Sep;63(9):911-8
pubmed: 15453090
Acta Neuropathol. 2000 Jan;99(1):31-8
pubmed: 10651025
J Mol Med (Berl). 2020 Oct;98(10):1467-1478
pubmed: 32851462
J Inherit Metab Dis. 2021 Mar;44(2):358-366
pubmed: 32965044
Ann Neurol. 1988 Dec;24(6):749-56
pubmed: 3144939
Curr Med Chem. 2018;25(18):2070-2081
pubmed: 29332568
Acta Neuropathol. 2012 Jan;123(1):1-11
pubmed: 22101365
Brain Pathol. 2023 Nov;33(6):e13199
pubmed: 37534760
Int J Mol Sci. 2021 Aug 18;22(16):
pubmed: 34445593
Biochim Biophys Acta. 2010 Feb;1797(2):113-28
pubmed: 19761752
Neuropathology. 2020 Oct;40(5):515-525
pubmed: 33463808
Neurology. 1992 Mar;42(3 Pt 1):545-50
pubmed: 1549215
Neurology. 2002 Jun 25;58(12):1791-800
pubmed: 12084879